20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Agios Pharmaceuticals (NASDAQ:AGIO) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Agios Pharmaceuticals beat estimated earnings by 4.0%, reporting an EPS of $-1.68 versus an estimate of $-1.75.
Revenue was up $5.58 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 1.65% drop in the share price the next day.
Here's a look at Agios Pharmaceuticals's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -1.81 | -1.69 | -1.59 | -1.41 |
| EPS Actual | -1.74 | -1.74 | -1.56 | -1.44 |
| Revenue Estimate | 2.71M | 560K | 2.60M | 2.48M |
| Revenue Actual | 832K | 0 | 0 | 0 |
To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!